203 related articles for article (PubMed ID: 16095764)
1. Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs.
Falcó JL; Lloveras M; Buira I; Teixidó J; Borrell JI; Méndez E; Terencio J; Palomer A; Guglietta A
Eur J Med Chem; 2005 Nov; 40(11):1179-87. PubMed ID: 16095764
[TBL] [Abstract][Full Text] [Related]
2. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile.
Menegatti R; Silva GM; Zapata-Sudo G; Raimundo JM; Sudo RT; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2006 Feb; 14(3):632-40. PubMed ID: 16198114
[TBL] [Abstract][Full Text] [Related]
4. Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors.
Petroski RE; Pomeroy JE; Das R; Bowman H; Yang W; Chen AP; Foster AC
J Pharmacol Exp Ther; 2006 Apr; 317(1):369-77. PubMed ID: 16399882
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic.
Foster AC; Pelleymounter MA; Cullen MJ; Lewis D; Joppa M; Chen TK; Bozigian HP; Gross RS; Gogas KR
J Pharmacol Exp Ther; 2004 Nov; 311(2):547-59. PubMed ID: 15256538
[TBL] [Abstract][Full Text] [Related]
6. Dipyrazolo[5,4-b:3',4'-d]pyridines. Synthesis, inhibition of benzodiazepine receptor binding and structure-activity relationships.
Melani F; Cecchi L; Colotta V; Filacchioni G; Martini C; Giannaccini G; Lucacchini A
Farmaco; 1989 Jun; 44(6):585-94. PubMed ID: 2553037
[TBL] [Abstract][Full Text] [Related]
7. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
[TBL] [Abstract][Full Text] [Related]
9. 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.
Wang Y; Duraiswami C; Madauss KP; Tran TB; Williams SP; Deng SJ; Graybill TL; Hammond M; Jones DG; Grygielko ET; Bray JD; Thompson SK
Bioorg Med Chem Lett; 2009 Sep; 19(17):4916-9. PubMed ID: 19664922
[TBL] [Abstract][Full Text] [Related]
10. 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor.
Mitchinson A; Atack JR; Blurton P; Carling RW; Castro JL; Curley KS; Russell MG; Marshall G; McKernan RM; Moore KW; Narquizian R; Smith A; Street LJ; Thompson SA; Wafford K
Bioorg Med Chem Lett; 2004 Jul; 14(13):3441-4. PubMed ID: 15177449
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type.
Trapani G; Franco M; Ricciardi L; Latrofa A; Genchi G; Sanna E; Tuveri F; Cagetti E; Biggio G; Liso G
J Med Chem; 1997 Sep; 40(19):3109-18. PubMed ID: 9301675
[TBL] [Abstract][Full Text] [Related]
12. Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
Primofiore G; Taliani S; Da Settimo F; Marini AM; La Motta C; Simorini F; Patrizi MP; Sergianni V; Novellino E; Greco G; Cosimelli B; Calderone V; Montali M; Besnard F; Martini C
J Med Chem; 2007 Apr; 50(7):1627-34. PubMed ID: 17335185
[TBL] [Abstract][Full Text] [Related]
13. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Besnard F; Costa B; Montali M; Martini C; Fohlin J; De Siena G; Aiello PM
J Med Chem; 2005 Oct; 48(21):6756-60. PubMed ID: 16220991
[TBL] [Abstract][Full Text] [Related]
14. Indiplon: the development of a new hypnotic.
Neubauer DN
Expert Opin Investig Drugs; 2005 Oct; 14(10):1269-76. PubMed ID: 16185169
[TBL] [Abstract][Full Text] [Related]
15. New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studies.
Fossa P; Pestarino M; Menozzi G; Mosti L; Schenone S; Ranise A; Bondavalli F; Trincavelli ML; Lucacchini A; Martini C
Org Biomol Chem; 2005 Jun; 3(12):2262-70. PubMed ID: 16010360
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
Sullivan SK; Petroski RE; Verge G; Gross RS; Foster AC; Grigoriadis DE
J Pharmacol Exp Ther; 2004 Nov; 311(2):537-46. PubMed ID: 15256540
[TBL] [Abstract][Full Text] [Related]
17. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors.
Moree WJ; Goldman P; Demaggio AJ; Christenson E; Herendeen D; Eksterowicz J; Kesicki EA; McElligott DL; Beaton G
Bioorg Med Chem Lett; 2008 Sep; 18(18):5126-9. PubMed ID: 18713665
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacology and molecular modeling of N-substituted 2-phenyl-indoles and benzimidazoles as potent GABA(A) agonists.
Falcó JL; Piqué M; González M; Buira I; Méndez E; Terencio J; Pérez C; Príncep M; Palomer A; Guglietta A
Eur J Med Chem; 2006 Aug; 41(8):985-90. PubMed ID: 16764969
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography.
Fookes CJ; Pham TQ; Mattner F; Greguric I; Loc'h C; Liu X; Berghofer P; Shepherd R; Gregoire MC; Katsifis A
J Med Chem; 2008 Jul; 51(13):3700-12. PubMed ID: 18557607
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.
Buchstaller HP; Siebert CD; Steinmetz R; Frank I; Berger ML; Gottschlich R; Leibrock J; Krug M; Steinhilber D; Noe CR
J Med Chem; 2006 Feb; 49(3):864-71. PubMed ID: 16451052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
